UT StrokeNet

UT 中风网

• 批准号: 9324372
• 负责人: Jennifer Juhl Majersik
• 金额: $ 36.66万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-30 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9324372
• 关键词: Acute; Address; Adult; Age; Agreement; Award; Bioinformatics; Biological Markers; Biometry; Blood Vessels; Caring; Cause of Death; Child; Childhood; Childhood stroke; Clinical; Clinical Investigator; Clinical Research; Clinical Sciences; Clinical Services; Clinical Trials; Collaborations; Communities; Community Hospitals; Contracts; Databases; Development; Development Plans; Discipline of Nursing; Effectiveness; Emergency Medicine; Enrollment; Extramural Activities; Faculty; Fellowship; Fostering; Functional Imaging; Funding; Genetic; Geography; Health Sciences; Hospitals; Image; Image Analysis; Incidence; Infarction; Informed Consent; Inpatients; Institutional Review Boards; Insurance; K-Series Research Career Programs; Laboratories; Magnetic Resonance Angiography; Medical; Medical center; Mentorship; Methodology; Methods; Minority; Molecular Medicine; Multicenter Trials; Multimedia; National Institute of Neurological Disorders and Stroke; Neurologist; Neurology; Neurosurgeon; Nurses; Participant; Patient Care; Patients; Pediatric Hospitals; Platelet aggregation; Population Heterogeneity; Positioning Attribute; Prevention; Program Development; Recovery; Recruitment Activity; Recurrence; Research; Research Design; Research Personnel; Research Training; Resources; Sampling; Science; Services; Site; Stroke; Stroke prevention; Thrombolytic Therapy; Thrombosis; Time; Training; Translational Research; United States National Institutes of Health; Universities; University Hospitals; Utah; Woman; base; career development; clinical investigation; community center; cost; disability; effectiveness trial; experience; genetic epidemiology; improved; infrastructure development; innovation; interest; malformation; multidisciplinary; neuroimaging; neurovascular; neurovascular coupling; outreach; point of care; population based; programs; protocol development; public health relevance; radiologist; research facility; skill acquisition; social media; socioeconomics; statistics; success; support network; tool; translational neuroscience; translational scientist

DESCRIPTION (provided by applicant): The University of Utah Health Sciences Center (UUHC) is ideally positioned to serve as a Regional Coordinating Center for the Network. "Utah StrokeNet" will serve the Intermountain West, a 5-state region encompassing 10% of the U.S. landmass. UUHC is the only regional academic medical facility and Comprehensive Stroke Center. UT StrokeNet will include Primary Children's Medical Center, the 4-state/15- spoke Telestroke Network, and Utah Regional NeuroNEXT network which includes Intermountain Medical Center (IMC), and numerous community hospitals. UT StrokeNet brings unique strengths to the Network: 1. Wide catchment: Via the collaboration between UUHC and IHC, almost every resident of any age with any insurance plan living in the Intermountain West will have access to the UT StrokeNet. The Utah Telestroke Network reaches remote corners in four states. 2. Strong support from the CCTS including clinical research space and nursing support, community engagement, biostatistics and study design support. 3. Neurology Clinical Trials Office, a department-supported resource for NIH-sponsored trials, which provides comprehensive support including contracting, IRB submission, protocol development, and coordination. 4. Availability of Adult and Pediatric Hospitals with specialized multidisciplinary stroke teams. UUHC benefits from University Hospital and PCMC each of which has strong stroke services with a demonstrated track record of successful participation in NIH-sponsored clinical trials 5. Innovative recruitment strategies, including social media-based methods and an institutional drive to utilize the established Telestroke Network 6. Career Development and Mentorship Resources: MS in Clinical Investigation, the KL2 program, and the Molecular Medicine Program. The resources have demonstrated effectiveness, with a career development award success rate of >90%. 7. Translational Research: UT StrokeNet will bring to the Network expertise in vascular malformations, thrombosis and platelet aggregation, neurovascular coupling and peri-infarct depolarization, stroke genetics, population-based genetic epidemiology, and functional imaging and imaging analysis.

描述（由申请人提供）：犹他州健康科学中心（UUHC）的大学是理想的定位，作为网络的区域协调中心。“犹他州中风网”将服务于山间西部，这是一个包含美国10%陆地面积的5个州的地区。UUHC是唯一的区域学术医疗设施和综合中风中心。UT StrokeNet将包括初级儿童医疗中心、4州/15辐Telestroke网络和犹他州区域NeuroNEXT网络，其中包括山间医疗中心（IMC）和许多社区医院。UT StrokeNet为网络带来了独特的优势：1。广泛的服务范围：通过UUHC和IHC之间的合作，几乎每个居住在Intermountain West的任何年龄的居民都可以访问UT StrokeNet。犹他州的Telestroke网络覆盖了四个州的偏远角落。2. CCTS的大力支持，包括临床研究空间和护理支持，社区参与，生物统计学和研究设计支持。3.神经病学临床试验办公室，一个部门支持的NIH申办的试验资源，提供全面的支持，包括合同，IRB提交，方案制定和协调。4.成人和儿科医院的可用性，以及专业的多学科卒中团队。UUHC受益于大学医院和PCMC，这两个医院都有强大的中风服务，成功参与NIH赞助的临床试验5。创新的招聘战略，包括基于社会媒体的方法和利用已建立的Telestroke Network的机构动力6。职业发展和导师资源：临床研究硕士，KL 2计划和分子医学计划。这些资源已经证明是有效的，职业发展奖的成功率超过90%。7.转化研究：UT StrokeNet将为网络带来血管畸形、血栓形成和血小板聚集、神经血管偶联和梗死周围去极化、中风遗传学、基于人群的遗传流行病学以及功能成像和成像分析方面的专业知识。